Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Lindsay A. Md Rosenwald

At a glance: Lindsay A. Md Rosenwald is CEO, President at Fortress Biotech (FBIO). Their latest SEC Form 4, filed Nov 19, 2026, reported a purchase of $116K. On file: 3 purchase lines ($253K) and 0 sale lines ($0).

CEO, President at Fortress Biotech, Inc. (FBIO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$253K / $0

Lindsay A. Md Rosenwald's InsiderPrint

23 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.

InsiderPrint of Lindsay A. Md Rosenwald: 23 trades, 2020 to 20262020: 3 buys, 0 sales2021: 0 buys, 0 sales2022: 2 buys, 0 sales2023: 6 buys, 0 sales2024: 9 buys, 0 sales2025: 0 buys, 0 sales2026: 3 buys, 0 sales

Reading this print: Almost only buys, trading about 4 times a year, typically $104K a trade.

  • Bump outward: a purchase (23)
  • Dent inward: a sale (0)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Magnolia Group, LLC10% Owner · CRMT · 100% matchTheir buys since 2022: 2 of 6 beat the S&P 500
  2. Jeffrey C. RoyalDirector · BOC · 100% matchTheir buys since 2022: 4 of 6 beat the S&P 500
  3. Mark Okey Decker Jr.CEO, President · XRN · 99% match
  4. Richard M. RiederPortfolio Manager · BCAT · 99% matchTheir buys since 2021: 2 of 7 beat the S&P 500
  5. JW GP, LLC10% Owner · ESTA · 99% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2023

From the SEC's insider data sets: each open-market buy by Lindsay A. Md Rosenwald, matched to how the stock did over the next 90 days against the S&P 500.

0 of 1 buy beat the S&P 500 (0%), median -86.8% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
ATXISep 12, 2023-86.8%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 19SEC FBIOFortress Biotech, Inc.First buy in 2 yrs Buy 64,4914,651,332 held (+1%) $1.80 $116K —
Nov 19SEC FBIOFortress Biotech, Inc.First buy in 2 yrs Buy 54,7764,706,108 held (+1%) $1.90 $104K —
Nov 19SEC FBIOFortress Biotech, Inc.First buy in 2 yrs Buy 17,4564,723,564 held (+0%) $1.86 $32K —
  • Buy

    CEO, President Lindsay A Md Rosenwald bought $116K of FBIO at $1.80 — first open-market purchase in our records.

Follow Lindsay A. Md Rosenwald

Get one email when Lindsay A. Md Rosenwald files a new purchase or sale. Free.

At most one email a day about Lindsay A. Md Rosenwald, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.